We are live on ! Find out more
TGTX icon

TG Therapeutics

87 hedge funds and large institutions have $320M invested in TG Therapeutics in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 22

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

14% more capital invested

Capital invested by funds: $282M → $320M (+$38.2M)

5% more funds holding

Funds holding: 8387 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

55% less call options, than puts

Call options by funds: $897K | Put options by funds: $1.98M

Holders
87
Holders Change
+4
Holders Change %
+4.82%
% of All Funds
2.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
36
Reduced
22
Closed
11
Calls
$897K
Puts
$1.98M
Net Calls
-$1.08M
Net Calls Change
-$714K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.35M -$61.3K -4,855 -4%
FAM
27
Fred Alger Management
New York
$960K
UBS Group
28
UBS Group
Switzerland
$897K +$721K +57,113 +316%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$781K +$14.3K +1,132 +2%
Charles Schwab
30
Charles Schwab
California
$705K
Deutsche Bank
31
Deutsche Bank
Germany
$682K -$1.2M -94,654 -62%
AllianceBernstein
32
AllianceBernstein
Tennessee
$682K +$89.7K +7,100 +14%
TA
33
Teachers Advisors
New York
$639K +$24K +1,902 +4%
WMSA
34
Weiss Multi-Strategy Advisers
New York
$608K
Morgan Stanley
35
Morgan Stanley
New York
$555K -$145K -11,447 -20%
Swiss National Bank
36
Swiss National Bank
Switzerland
$544K
Creative Planning
37
Creative Planning
Kansas
$447K +$40.4K +3,200 +9%
OAM
38
Oxford Asset Management
United Kingdom
$443K +$466K +36,873 New
HT
39
HAP Trading
New York
$438K -$171K -13,576 -27%
CS
40
Credit Suisse
Switzerland
$420K +$182K +14,412 +69%
Group One Trading
41
Group One Trading
Illinois
$417K -$800K -63,331 -64%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$410K +$30.3K +2,395 +7%
Citadel Advisors
43
Citadel Advisors
Florida
$374K +$123K +9,757 +45%
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$303K
QSS
45
Quantitative Systematic Strategies
Florida
$302K +$319K +25,270 New
LCM
46
Landscape Capital Management
New Jersey
$298K +$316K +24,990 New
TI
47
Trexquant Investment
Connecticut
$286K +$302K +23,950 New
NFA
48
Nationwide Fund Advisors
Ohio
$280K +$7.74K +613 +3%
Squarepoint
49
Squarepoint
New York
$280K +$297K +23,500 New
AIG
50
American International Group
New York
$266K -$455 -36 -0.2%

TGTX Hedge Fund Activity: Q4 2015 in Review

87 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q4 2015, worth a combined $320M — up 14% from $282M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TGTX positions and 11 closed out — a net gain of 4 holders — while 36 added to existing stakes and 22 trimmed.

The largest buyer was UBS AM, adding an estimated $17.7M. The largest seller was State Street, cutting an estimated $18.9M.

  • 87 institutional investors held TG Therapeutics (TGTX) as of Q4 2015, up from 83 in Q3 2015.
  • Funds reported $320M of TG Therapeutics stock for Q4 2015, up 14% quarter-over-quarter.
  • 15 funds opened new TG Therapeutics positions in Q4 2015 and 11 closed out, a net change of +4 holders.
  • The largest TG Therapeutics buyer in Q4 2015 was UBS AM, an estimated $17.7M added.
  • The largest TG Therapeutics seller in Q4 2015 was State Street, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2015.